Pomalidomide

Overview

Pomalidomide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL43452).

API suppliers (1)

Suppliers of Pomalidomide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• MATRIX PHARMACORP PRIVATE LTD2 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (24 approved US products), the latest listed US patent on Pomalidomide expires 21 Dec 2031 and exclusivity 14 Nov 2027. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione

Canonical SMILES

C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N

InChIKey

UVSMNLNDYGZFPF-UHFFFAOYSA-N